TTF
Showing 1 - 25 of 419
NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
- Atezolizumab
- +5 more
- (no location specified)
Jan 18, 2023
Pancreas Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Jacksonville (Modified GCN+TTF treatment)
Recruiting
- Pancreas Cancer
- +3 more
- Modified GCN+TTF treatment
-
Jacksonville, FloridaMayo Clinic
Apr 4, 2022
Pancreas Cancer, Locally Advanced, Locally Advanced Pancreatic Adenocarcinoma Trial in Miami (Stereotactic Ablative Body
Not yet recruiting
- Pancreas Cancer
- +2 more
- Stereotactic Ablative Body Radiation (SABR)
- Tumor Treating Fields (TTF)
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Dec 27, 2022
Chronic Myelogenous Leukemia Trial in Tampa (Therapy for Targeted Therapy-related Fatigue (TTF), Wait-List Control Condition
Completed
- Chronic Myelogenous Leukemia
- Therapy for Targeted Therapy-related Fatigue (TTF)
- Wait-List Control Condition (WLC)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 15, 2021
Glioma Trial in Atlanta (Optune device)
Recruiting
- Glioma
- Optune device
-
Atlanta, Georgia
- +2 more
May 12, 2022
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Malignant Solid Tumors, Lymphomas Trial in Muenster (tTF-NGR)
Completed
- Malignant Solid Tumors
- Lymphomas
- tTF-NGR
-
Muenster, NRW, GermanyUniversity Hospital Muenster
Nov 12, 2020
Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))
Terminated
- Brain Metastases
- Small Cell Lung Cancer
- NovoTTF-200A
- Stereotactic Radiosurgery (SRS)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
Feb 17, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
CNS Tumors, Primary Trial (Optune TTF device)
Withdrawn
- Central Nervous System Neoplasms, Primary
- Optune TTF device
- (no location specified)
Aug 31, 2020
TFF-1 and TTF-3 in Periodontal Diseases
Completed
- Periodontal Diseases
- biofluids
-
Giresun, TurkeyZeynep Pinar Keles Yucel
May 25, 2020
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022
Extensive Stage Small Cell Lung Carcinoma Trial in Nashville (procedure, device, other)
Terminated
- Extensive Stage Small Cell Lung Carcinoma
- Tumor Treating Fields (TTF) Therapy
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 17, 2020
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Digital Photography
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Feb 28, 2023
Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)
Not yet recruiting
- Non Small Cell Lung Cancer
- carboplatin chemotherapy
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute
Nov 3, 2023
Low-dose Radiation Abdominal Computed Tomography
Not yet recruiting
- CT Examination of the Abdomen
- CT Radiation Doses
-
Shandong, Jinan Shandong, ChinauCT960+
Nov 16, 2023
PROSPECT - Profiling of Resistance Patterns & Oncogenic
Recruiting
- Lung Cancer
- Cancer of Thorax
- Group Specific Aim 1
- +5 more
-
Houston, TexasM D Anderson Caner Center
Jun 29, 2022
Risarg® Combined With Endocrine Therapy or Chemotherapy in
Not yet recruiting
- HR+HER2- Advanced Breast Cancer
- Ribociclib
- Combination chemotherapy
- (no location specified)
Nov 20, 2023
Nonsmall Cell Lung Cancer, NSCLC Trial in Worldwide (NovoTTF-200T, Immune checkpoint inhibitors or docetaxel)
Active, not recruiting
- Nonsmall Cell Lung Cancer
- NSCLC
- NovoTTF-200T
- Immune checkpoint inhibitors or docetaxel
-
Birmingham, Alabama
- +123 more
Oct 13, 2022
Glioblastoma, Newly Diagnosed Glioblastoma Trial in Stanford (device, drug, radiation)
Recruiting
- Glioblastoma
- Newly Diagnosed Glioblastoma
- Optune
- +3 more
-
Stanford, CaliforniaStanford University
Aug 1, 2022
Metastatic Pancreatic Cancer Trial in Long Branch, New Brunswick (Folfirinox alternating with Gemcitabine-nab-Paclitaxel)
Recruiting
- Metastatic Pancreatic Cancer
- Folfirinox alternating with Gemcitabine-nab-Paclitaxel
-
Long Branch, New Jersey
- +1 more
Jun 8, 2021
Uveal Melanoma Trial in Scottsdale (Novocure Optune, Opdivo, Yervoy)
Recruiting
- Uveal Melanoma
- Novocure Optune
- +2 more
-
Scottsdale, ArizonaHonorHealth Research Institute
Mar 21, 2022